Back
Sarepta Therapeutics Stock Price Chart
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
131.89
Seasonality Move:
14.17%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.- The current trend is moderately bullish and SRPT is experiencing slight buying pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 132.86 | Sell |
| 20-day SMA: | 125.9 | Buy |
| 50-day SMA: | 125.49 | Buy |
| 200-day SMA: | 112.87 | Buy |
| 8-day EMA: | 131.79 | Buy |
| 20-day EMA: | 128.8 | Buy |
| 50-day EMA: | 125.75 | Buy |
| 200-day EMA: | 117.52 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.57 | Buy |
| Relative Strength Index (14 RSI): | 59 | Buy |
| Chaikin Money Flow: | 285209 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.48 - 132.12) | Buy |
| Bollinger Bands (100): | (109.28 - 132.8) | Buy |
Sarepta Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 131.82 while SRPT 8-day simple moving average is 132.86, which is a Sell signal.
- The stock price of SRPT is 131.82 while Sarepta Therapeutics 20-day SMA is 125.90, which makes it a Buy.
- Sarepta Therapeutics 50-day simple moving average is 125.49 while SRPT share price is 131.82, making it a Buy technically.
- SRPT stock price is 131.82 and Sarepta Therapeutics 200-day simple moving average is 112.87, creating a Buy signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $131.82. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
12.46B
Price in USD:
131.82
Share Volume:
735.54K
Sarepta Therapeutics 52-Week Range
52-Week High:
159.89
52-Week Low:
55.25
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 131.82 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 131.82 while SRPT 8-day exponential moving average is 131.79, which is a Buy signal.
- The stock price of SRPT is 131.82 while Sarepta Therapeutics 20-day EMA is 128.80, which makes it a Buy.
- Sarepta Therapeutics 50-day exponential moving average is 125.75 while SRPT share price is 131.82, making it a Buy technically.
- SRPT stock price is 131.82 and Sarepta Therapeutics 200-day simple moving average is 117.52, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.85 per share, an increase next quarter of $1.52 per share, an increase this year of $5.62 per share, and an increase next year of $6.11 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is 2.57, suggesting Sarepta Therapeutics is a Buy
- Sarepta Therapeutics Relative Strength Index (RSI) is 59, which suggest Sarepta Therapeutics is overbought
- The Bollinger Bands (25) for Sarepta Therapeutics is (119.48 - 132.12), which suggest Sarepta Therapeutics is a Buy
- The Bollinger Bands (100) for Sarepta Therapeutics is (109.28 - 132.8), which suggest Sarepta Therapeutics is a Buy
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.